Is failure mode and effect analysis reliable?

Journal of Patient Safety

Volumn 5, Issue 2, 2009, Pages 86-94

  Shebl, Nada Atef ^a   Franklin, Bryony Dean ^b   Barber, Nick ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Anti infectives; Antibacterial; Antibiotics; Antimicrobials; Failure mode and effect analysis; Hospital; Infection; Patient safety; Reliability; Risk assessment

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN; VANCOMYCIN;

ADULT; ARTICLE; HUMAN; MEDICATION ERROR; RISK ASSESSMENT; SAFETY;

ADULT; ANTI-BACTERIAL AGENTS; GENTAMICINS; HUMANS; MEDICATION ERRORS; RISK ASSESSMENT; SAFETY MANAGEMENT; VANCOMYCIN;

EID: 68549115471     PISSN: 15498417     EISSN: 15498425     Source Type: Journal    
DOI: 10.1097/PTS.0b013e3181a6f040     Document Type: Article

References (27)

1. Joint Commission on Accreditation of Healthcare Organizations (JCAHO). Failure Mode and Effects Analysis in Health Care: Proactive Risk Reduction. 2nd ed. United States: Joint Commission Resources Inc. (JCR); 2005.
2. Williams E, Talley T. The use of failure mode effect and criticality analysis in a medication error subcommittee. Hosp Pharm. 1994; 29:331-338.
3. Duwe B, Fuchs BD, Hansen-Flaschen J. Failure mode and effects analysis application to critical care medicine. Crit Care Clin. 2005; 21(1):21-30.
4. Esmail R, Cummings C, Dersch D, et al. Using Healthcare Failure Mode and Effect Analysis tool to review the process of ordering and administrating potassium chloride and potassium phosphate. Healthc Q. 2005;8:73-80.
5. American Society for Health Care Risk Management (ASHRM). Strategies and tips for maximizing failure mode and effect analysis in your organization, 2002. Available at: www.ashrm.org/ashrm/resources/ files/FMEAwhitepaper.pdf. Accessed June 4, 2008.
6. National Patient Safety Agency (NPSA) NHS. Seven steps to patient safety, 2004. Available at: http://www.npsa.nhs.uk/site/media/ documents/499- sevensteps-overview(2).pdf. Accessed June 19, 2006.
7. Veteran's Administration National Center for Patient Safety (VA NCPS). The basics of healthcare failure mode and effect analysis, 2005. Available at: http://www.va.gov/ncps/SafetyTopics/HFMEA/ HFMEAIntro.doc. Accessed October 11, 2006.
8. Wetterneck TB, Skibinski KA, Roberts TL, et al. Using failure mode and effects analysis to plan implementation of smart I.V. pump technology. Am J Health Syst Pharm. 2006;63:1528-1538.
9. Department of Defense Patient Safety Center. Guidelines for Failure Mode and Effect Analysis for Automotive, Aerospace and General Manufacturing Industries. Portland, OR: Dyadem Press-CRC Press; 2003.
10. McDermott R, Mikulak RJ, Beauregard MR. The Basics of FMEA. Boca Raton, FL: Productivity Inc; 1996.
11. Bonnabry P, Cingria L, Sadeghipour H, et al. Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions. Qual Saf Health Care. 2005;14(2):93-98.
12. Bonnabry P, Cingria L, Ackermann M, et al. Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process. Int J Qual Health Care. 2006;18(1):9-16.
13. Robinson DL, Heigham M, Clark J. Using failure mode and effects analysis for safe administration of chemotherapy to hospitalized children with cancer. Jt Comm J Qual Patient Saf. 2006;32(3):161-166.
14. Adachi W, Lodolce AE. Use of failure mode and effects analysis in improving the safety of I.V. drug administration. Am J Health Syst Pharm. 2005;62(9):917-920.
15. Cheung DS, Maygers J, Khouri-Stevens Z, et al. Failure modes and effects analysis: minimizing harm to our bariatric patients. Bariatric Nursing and Surgical Patient Care. 2006;1(2):107-114.
16. Kunac DL, Reith DM. Identification of priorities for medication safety in neonatal intensive care. Drug Saf. 2005;28:(3): 251-261.
17. Kozakiewicz JM, Benis LJ, Fisher SM, et al. Safe chemotherapy administration: using failure mode and effects analysis in computerized prescriber order entry. Am J Health Syst Pharm. 2005;62:1813-1816.
18. Burgmeier J. Failure mode and effect analysis: an application in reducing risk in blood transfusion. Jt Comm J Qual Improv. 2002;28(6):331-339.
19. Apkon M, Leonard J, Probst L, et al. Design of a safer approach to intravenous drug infusions: failure mode effects analysis. Qual Saf Health Care. 2004;13(4):265-271.
20. Day S, Dalto J, Fox J, et al. Utilization of failure mode effects analysis in trauma patient registration. Qual Manag Health Care. 2007;16(4): 342-348.
21. Van Tilburg CM, Leistikow IP, Rademaker CM, et al. Health Care Failure Mode and Effect Analysis: a useful proactive risk analysis in a pediatric oncology ward. Qual Saf Health Care. 2006;15(1):58-63.
22. Wehrli-Veit M, Riley JB, Austin JW. A failure mode effect analysis on extracorporeal circuits for cardiopulmonary bypass. J Extra Corpor Technol. 2004;36(4):351-357.
23. Reason J. Understanding adverse events: human factors. In: Vincent C, ed. Clinical Risk Management. London: BMJ Publishing Group; 1995:31-54.
24. Dennison R. Creating an organizational culture for medication safety. Nurs Clin North Am. 2005;40:1-23.
25. Taxis K, Barber N. Causes of intravenous medication errors: an ethnographic study. Qual Saf Health Care. 2003;12(5):343-347.
26. Dean B, Schachter M, Vincent C, et al. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet. 2002;359: 1373-1378.
27. Siegel S. Non Parametric Statistics for Behavioral Sciences. International Student Edition. Japan: McGrwa-Hill Kogakusha, Ltd; 1956:18-34.